Search

Author/Creator Navarra, Sandra

31. Secukinumab improves physical function and quality of life and inhibits structural damage in patients with PsA with sustained remission or low disease activity: results from the 2-year phase 3 FUTURE 5 study. Issue 2 (24th April 2023)

Authors:
Coates, Laura C; Mease, Philip J; Gladman, Dafna D; Navarra, Sandra; Bao, Weibin; Gaillez, Corine
Journal:
RMD open
Issue:
Volume 9:Issue 2(2023)
Page Start:
Record Type:
Journal Article
View Content:
Available online (eLD content is only available in our Reading Rooms) ↗

32. Secukinumab provides sustained improvement in signs and symptoms and low radiographic progression in patients with psoriatic arthritis: 2-year (end-of-study) results from the FUTURE 5 study. Issue 2 (30th July 2021)

Authors:
Mease, Philip J; Landewé, Robert; Rahman, Proton; Tahir, Hasan; Singhal, Atul; Boettcher, Elke; Navarra, Sandra; Readie, Aimee; Mpofu, Shephard; Delicha, Eumorphia Maria; Pricop, Luminita; van der Heijde, Desirée
Journal:
RMD open
Issue:
Volume 7:Issue 2(2021)
Page Start:
Record Type:
Journal Article
View Content:
Available online (eLD content is only available in our Reading Rooms) ↗

33. Secukinumab provides sustained low rates of radiographic progression in psoriatic arthritis: 52-week results from a phase 3 study, FUTURE 5. (5th October 2019)

Authors:
van der Heijde, Désirée; Mease, Philip J; Landewé, Robert B M; Rahman, Proton; Tahir, Hasan; Singhal, Atul; Boettcher, Elke; Navarra, Sandra; Zhu, Xuan; Ligozio, Gregory; Readie, Aimee; Mpofu, Shephard; Pricop, Luminita
Journal:
Rheumatology
Issue:
Volume 59:Number 6(2020)
Page Start:
1325
Record Type:
Journal Article
View Content:
Available online (eLD content is only available in our Reading Rooms) ↗

34. The Asia-Pacific League of Associations for Rheumatology consensus statements on the management of systemic lupus erythematosus. (July 2021)

Authors:
Mok, Chi Chiu; Hamijoyo, Laniyati; Kasitanon, Nuntana; Chen, Der Yuan; Chen, Sheng; Yamaoka, Kunihiro; Oku, Kenji; Li, Meng Tao; Zamora, Leonid; Bae, Sang-Cheol; Navarra, Sandra; Morand, Eric F; Tanaka, Yoshiya
Journal:
Lancet
Issue:
Volume 3:Number 7(2021)
Page Start:
e517
Record Type:
Journal Article
View Content:
Available online (eLD content is only available in our Reading Rooms) ↗

35. THU0253 EFFECT OF GLUCOCORTICOIDS ON DAMAGE ACCRUAL IN SLE PATIENTS WITH NO CLINICAL OR SEROLOGICAL DISEASE ACTIVITY. (June 2019)

Authors:
Apostolopoulos, Diane; Kandane-Rathnayake, Rangi; Louthrenoo, Worawit; Luo, Shue Fen; Wu, Yeong-Jian; Lateef, Aisha; Golder, Vera; Sockalingam, Sargunan; Navarra, Sandra; Zamora, Leonid; Hamijoyo, Laniyati; Katsumata, Yasuhiro; Harigai, Masayoshi; Chan, Madelynn; O'neill, Sean; Goldblatt, Fiona; ...
Journal:
Annals of the rheumatic diseases
Issue:
Volume 78(2019)Supplement 2
Page Start:
404
Record Type:
Journal Article
View Content:
Available online (eLD content is only available in our Reading Rooms) ↗

36. Treat-to-target in systemic lupus erythematosus: recommendations from an international task force. Issue 6 (16th April 2014)

Authors:
van Vollenhoven, Ronald F; Mosca, Marta; Bertsias, George; Isenberg, David; Kuhn, Annegret; Lerstrøm, Kirsten; Aringer, Martin; Bootsma, Hendrika; Boumpas, Dimitrios; Bruce, Ian N; Cervera, Ricard; Clarke, Ann; Costedoat-Chalumeau, Nathalie; Czirják, László; Derksen, Ronald; Dörner, Thomas; Gordo...
Journal:
Annals of the rheumatic diseases
Issue:
Volume 73:Issue 6(2014)
Page Start:
958
Record Type:
Journal Article
View Content:
Available online (eLD content is only available in our Reading Rooms) ↗